Jaguar Health Inc (NASDAQ:JAGX) shares were down 18.2% on Monday . The company traded as low as $0.26 and last traded at $0.27. Approximately 12,405,623 shares traded hands during trading, an increase of 194% from the average daily volume of 4,220,825 shares. The stock had previously closed at $0.33.
Separately, ValuEngine downgraded Jaguar Health from a “buy” rating to a “hold” rating in a research note on Thursday, January 24th.
The company has a quick ratio of 0.31, a current ratio of 0.46 and a debt-to-equity ratio of 1.03.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4248616/jaguar-health-jagx-shares-down-18-2.html.
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Recommended Story: Federal Reserve
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.